Compared to previous studies (Table 4),10, 11, 14, 16, 32 patients in our cohort were older at the time of LM diagnosis, more patients had HR‐positive primary breast cancer, more patients received anti‐HER2 targeted therapy and fewer patients underwent RT and IT procedures. The gene discussed is ERBB2; the disease is breast carcinoma.